Cargando…

High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern

INTRODUCTION. Enterococcus spp. is considered as important etiological agents of nosocomial infections. However, a little is known about the epidemiology of vancomycin resistant Enterococcus faecalis (VREF). The aim of this study was to investigate the frequency of VREF and detecting of two prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales: SABOUNI, F., MOVAHEDI, Z., MAHMOUDI, S., POURAKBARI, B., KESHAVARZ VALIAN, S., MAMISHI, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SRL 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289031/
https://www.ncbi.nlm.nih.gov/pubmed/28167857
_version_ 1782504442682146816
author SABOUNI, F.
MOVAHEDI, Z.
MAHMOUDI, S.
POURAKBARI, B.
KESHAVARZ VALIAN, S.
MAMISHI, S.
author_facet SABOUNI, F.
MOVAHEDI, Z.
MAHMOUDI, S.
POURAKBARI, B.
KESHAVARZ VALIAN, S.
MAMISHI, S.
author_sort SABOUNI, F.
collection PubMed
description INTRODUCTION. Enterococcus spp. is considered as important etiological agents of nosocomial infections. However, a little is known about the epidemiology of vancomycin resistant Enterococcus faecalis (VREF). The aim of this study was to investigate the frequency of VREF and detecting of two prevalent resistance genes (vanA, vanB) at Children Medical Center Hospital, an Iranian referral pediatric Hospital. MATERIALS AND METHODS. During January 2013 to December 2013, 180 E. faecalis were isolated from clinical samples of hospitalized children. Antimicrobial testing was performed by Kirby-Bauer disk diffusion to gentamicin, amikacin, ceftriaxone, cefotaxime, ceftazidim, cefixime, piperacillin/tazobactam, cefepime, trimethoprim/sulfamethoxazole, erythromycin, clindamycin, linezolide and E-test method vancomycin and teicoplanin according to Clinical Laboratories Standards Institute (CLSI). Two prevalent resistance genes (vanA, vanB) were investigated in VREF isolates. RESULTS. Seventy-five (42%) of patients were male and 105 (58%) were female. Mean age of patients was 34.74 months. Cephalosporin resistance was found in majority of E. faecalis isolates (98.7 to ceftazidim, 95% to cefixime, 93.3% to ceftriaxone, and 89.4% to cefotaxime). Most of the isolated were susceptible to cefepime (91.7%). In addition, high level of erythromycin and clindamycin resistance was reported (93.4% and 91.2%). There were no linezolid-resistant E. faecalis among all isolates. Teicoplanin resistance was observed in 13.8% of E. faecalis (n = 25). Minimum Inhibitory concentration (MIC) ≥ 32 μg/ml for vancomycin was found in 29 isolates (16%) and vanA gene was detected in 21 (72%) VREF strains, while vanB gene was not detected in any of these isolates. The mortality rate of all cases was 3.4%. CONCLUSIONS. This study revealed high rate of vancomycin resistance in E. faecalis strains. Therefore, periodic surveillance of antibacterial susceptibilities is highly recommended to detect emerging resistance.
format Online
Article
Text
id pubmed-5289031
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Pacini Editore SRL
record_format MEDLINE/PubMed
spelling pubmed-52890312017-02-06 High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern SABOUNI, F. MOVAHEDI, Z. MAHMOUDI, S. POURAKBARI, B. KESHAVARZ VALIAN, S. MAMISHI, S. J Prev Med Hyg Original Article INTRODUCTION. Enterococcus spp. is considered as important etiological agents of nosocomial infections. However, a little is known about the epidemiology of vancomycin resistant Enterococcus faecalis (VREF). The aim of this study was to investigate the frequency of VREF and detecting of two prevalent resistance genes (vanA, vanB) at Children Medical Center Hospital, an Iranian referral pediatric Hospital. MATERIALS AND METHODS. During January 2013 to December 2013, 180 E. faecalis were isolated from clinical samples of hospitalized children. Antimicrobial testing was performed by Kirby-Bauer disk diffusion to gentamicin, amikacin, ceftriaxone, cefotaxime, ceftazidim, cefixime, piperacillin/tazobactam, cefepime, trimethoprim/sulfamethoxazole, erythromycin, clindamycin, linezolide and E-test method vancomycin and teicoplanin according to Clinical Laboratories Standards Institute (CLSI). Two prevalent resistance genes (vanA, vanB) were investigated in VREF isolates. RESULTS. Seventy-five (42%) of patients were male and 105 (58%) were female. Mean age of patients was 34.74 months. Cephalosporin resistance was found in majority of E. faecalis isolates (98.7 to ceftazidim, 95% to cefixime, 93.3% to ceftriaxone, and 89.4% to cefotaxime). Most of the isolated were susceptible to cefepime (91.7%). In addition, high level of erythromycin and clindamycin resistance was reported (93.4% and 91.2%). There were no linezolid-resistant E. faecalis among all isolates. Teicoplanin resistance was observed in 13.8% of E. faecalis (n = 25). Minimum Inhibitory concentration (MIC) ≥ 32 μg/ml for vancomycin was found in 29 isolates (16%) and vanA gene was detected in 21 (72%) VREF strains, while vanB gene was not detected in any of these isolates. The mortality rate of all cases was 3.4%. CONCLUSIONS. This study revealed high rate of vancomycin resistance in E. faecalis strains. Therefore, periodic surveillance of antibacterial susceptibilities is highly recommended to detect emerging resistance. Pacini Editore SRL 2016-12 /pmc/articles/PMC5289031/ /pubmed/28167857 Text en © Copyright by Pacini Editore SRL, Pisa, Italy http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
SABOUNI, F.
MOVAHEDI, Z.
MAHMOUDI, S.
POURAKBARI, B.
KESHAVARZ VALIAN, S.
MAMISHI, S.
High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern
title High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern
title_full High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern
title_fullStr High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern
title_full_unstemmed High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern
title_short High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern
title_sort high frequency of vancomycin resistant enterococcus faecalis in children: an alarming concern
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289031/
https://www.ncbi.nlm.nih.gov/pubmed/28167857
work_keys_str_mv AT sabounif highfrequencyofvancomycinresistantenterococcusfaecalisinchildrenanalarmingconcern
AT movahediz highfrequencyofvancomycinresistantenterococcusfaecalisinchildrenanalarmingconcern
AT mahmoudis highfrequencyofvancomycinresistantenterococcusfaecalisinchildrenanalarmingconcern
AT pourakbarib highfrequencyofvancomycinresistantenterococcusfaecalisinchildrenanalarmingconcern
AT keshavarzvalians highfrequencyofvancomycinresistantenterococcusfaecalisinchildrenanalarmingconcern
AT mamishis highfrequencyofvancomycinresistantenterococcusfaecalisinchildrenanalarmingconcern